<DOC>
	<DOCNO>NCT02575248</DOCNO>
	<brief_summary>This study aim investigate fertility outcome endometriosis suppression dienogest 2mg / day 3 month follow induction ovulation 3 month endometriosis patient stage I II .</brief_summary>
	<brief_title>Induction Ovulation Clomiphene Citrate Following Laparoscopic Surgery Endometriosis Stage 1 Stage 2 With Without Suppression Dienogest</brief_title>
	<detailed_description>Study population : Sample size : Group sample size study 155 group one 155 group two achieve 80 % power detect difference group proportion 0.10 . The proportion group one ( treatment group ) assume 0.1000 null hypothesis 0.2000 alternative hypothesis . The proportion group two ( control group ) 0.1000 . The test statistic use .the one-sided Z test un pool variance . The significance level test target 0.05 Primary outcome : Clinical pregnancy rate endometriosis patient stage I II undergo endometriosis suppression dienogest 2mg / day 3 month follow induction ovulation 3 month . Secondary outcome : Ovulation rate endometriosis patient stage I II undergo endometriosis suppression dienogest 2mg / day 3 month follow induction ovulation 3 month . Inclusion criterion : All woman recruit study definitive diagnosis endometriosis grade I grade II via laparoscopy randomization . Method Randomization : A Computerized generated list internet http : //www.sealedenvelope.com/sirnple-randomiser/vl/lists Allocation concealment : Closed envelope method nurse participate study Intervention It prospective randomize controlled trial . Investigation do recruitment randomization . The patient randomize two group : Group A : patient receive dienogest 2 mg ( visanne 2mg sanofi Aventis ) daily three month follow induction ovulation clomiphene citrate ( clomid 5mg sanofi aventis three month . Group B : Patients undergo induction ovulation clomiphene citrate ( clomid 50mg sanofi aventis ) three month . Protocol induction ovulation 1 . Clomiphen citrate ( clomid 50mg sanofi aventis ) give day two menstrual cycle dose 50 mg twice daily five day . 2 . Folliculometry perform every day start seventh day cycle till ovulation occur use 6 Mhz transvaginal probe till follicles reach 18 - 20 mm . 3 . A trigger ovulation HCG 10000iu give IM follicle reach 18- 22 mm . The couple advise intercourse 36 hrs daily 7 day . 4 . Prontogest 400 mg ( progest 400 mg Sanofi Aventis ) daily vaginal suppository luteal phase support . 5 . Pregnancy diagnose quantitative B HCG blood test 2 day miss period . 6 . Clinical pregnancy rate diagnose TVUS confirm fetal echo pulsation 5-7 week gestation . The sonographer confirm clinical pregnancy blind group . Statistical Analysis Statistical Method : Statistical analysis perform use Microsoft Excel version 2010 statistical package social science ( SPSS ) windows version l S.O . Continious data present range , mean standard deviation ( parametric ) ; range ; median inter quartile range ( non - parametric ) . Dichotomous categorical data present number percentage . Difference independent estimate use independent student 's t-test ( parametric continuous variable ) , Manny whitney test U-test ( non -parametric continuous variable ) Chi-square test ( categorical variable ) . Receiver operator characteristic curve construct assess predictability express term sensitivity , specificity , positive negative predictive value . Significance level 0.05 . Ethical legal aspect Delegation investigator responsibility : The investigator ensure person assist trial adequately inform protocol , amendment protocol , study treatment , trial-related duty function . Patient information inform consent : Before admit clinical study , patient must consent participate nature , scope possible consequence clinical study explain form understandable write consent obtain . Confidentiality : Only patient initial record file , patient name appear document , must keep privacy investigator . The investigator maintain personal patient identification list ( patient initial correspond patient name ) enable record identify . Protocol approval : Before begin study accordance local regulation follow , protocol correspond document declare Ethical Research approval council obstetrics Department , Ain Shams University .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Clomiphene</mesh_term>
	<mesh_term>Enclomiphene</mesh_term>
	<mesh_term>Zuclomiphene</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<mesh_term>Nandrolone</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>1 . All woman recruit study definitive diagnosis endometriosis grade I grade II via laparoscopy randomization . 1 . Male factor . 2 . Other factor e.g . mullerian duct anomaly , hydrosalpinx . 3 . Age &gt; 35 year . 4 . Day 3 FSH &gt; 14 mlu/ml antimullerian hormone &lt; 1 ng/1 .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>dienogest</keyword>
	<keyword>infertility</keyword>
	<keyword>endometriosis</keyword>
</DOC>